Analyzing the cancer methylome through targeted bisulfite sequencing. (Abstract)
Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer. (Abstract)
Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients. (Abstract)